microdosing glp 1 EllieMD Microdosing GLP-1s: Risks & Considerations
Description
In my practice, I have seen countless women who, despite their best efforts, cannot achieve their weight loss goals

When your ALT levels are high, it signals poor metabolic health

And through the International Quit & Recovery Registry, launched by founding director Warren Bickel, we learn directly from people in recovery what helps them succeed. Recently published research by Virginia Tech includes the following findings: Brain imaging studies reveal a promising therapy for addiction : Since addiction tends to favour immediate rewards over long-term health, researchers tested episodic future thinking, a technique that encourages people to vividly picture positive future events

GLP-1 receptor agonists are generally contraindicated in pregnancy and breastfeeding, and some have specific restrictions in severe renal impairment

doi: 10.1146/annurev-nutr-071812-161148 45 SharmaAAnandSKSinghNDwivediUNKakkarP

For current clinical use, semaglutide has no peer in terms of evidence quality, regulatory status, and real-world experience
